Where should oral anticoagulation monitoring take place?
作者信息
Hobbs F D, Fitzmaurice D A
出版信息
Br J Gen Pract. 1997 Aug;47(421):479-80.
Abstract
摘要
相似文献
1
Where should oral anticoagulation monitoring take place?口服抗凝治疗监测应在哪里进行？
Br J Gen Pract. 1997 Aug;47(421):479-80.
2
Monitoring oral anticoagulant therapy--INR values for the Owren prothrombin time.监测口服抗凝治疗——奥伦凝血酶原时间的国际标准化比值（INR）值。
Thromb Haemost. 2004 Feb;91(2):210-2.
3
International Normalized Ratio (INR): an improved way to monitor oral anticoagulant therapy.国际标准化比值（INR）：监测口服抗凝治疗的一种改进方法。
Nurse Pract. 1995 Sep;20(9):15-6, 21-2.
4
Oral anticoagulation monitoring.口服抗凝监测。
Br J Gen Pract. 1997 Nov;47(424):747-8.
5
Optimizing the efficacy and safety of oral anticoagulant therapy: high-quality dose management, anticoagulation clinics, and patient self-management.优化口服抗凝治疗的疗效和安全性：高质量剂量管理、抗凝门诊及患者自我管理。
Semin Vasc Med. 2003 Aug;3(3):261-70. doi: 10.1055/s-2003-44462.
6
Oral anticoagulation in primary care.基层医疗中的口服抗凝治疗。
Br J Gen Pract. 1997 Aug;47(421):527.
7
INR and PTR anticoagulation values.国际标准化比值（INR）和凝血酶原时间比值（PTR）抗凝值。
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996 Apr;81(4):377-8. doi: 10.1016/s1079-2104(96)80006-0.
8
Monitoring oral anticoagulant therapy with point-of-care devices: correlations and caveats.使用即时检测设备监测口服抗凝治疗：相关性及注意事项
Clin Chem. 1997 Sep;43(9):1785-6.
9
Assessing nonvitamin K antagonist oral anticoagulants (NOACs) in the laboratory.在实验室中评估非维生素K拮抗剂口服抗凝药（NOACs）。
Int J Lab Hematol. 2015 May;37 Suppl 1:46-51. doi: 10.1111/ijlh.12350.
10
Oral anticoagulant initiation: rationale for the use of warfarin dosing nomograms.口服抗凝剂的起始治疗：使用华法林剂量计算图的理论依据。
Semin Vasc Med. 2003 Aug;3(3):255-60. doi: 10.1055/s-2003-44461.
引用本文的文献
1
Primary care anticoagulant management using near patient testing.使用即时检验进行基层医疗抗凝管理。
Ir J Med Sci. 2003 Jan-Mar;172(1):30-2. doi: 10.1007/BF02914783.
2
Determination of bleeding risk using genetic markers in patients taking phenprocoumon.使用基因标记物确定服用苯丙香豆素患者的出血风险。
Eur J Clin Pharmacol. 2003 Jul;59(3):213-9. doi: 10.1007/s00228-003-0580-8. Epub 2003 May 1.
3
Oral anticoagulation monitoring.口服抗凝监测。
Br J Gen Pract. 1997 Nov;47(424):747-8.
4
Oral anticoagulation monitoring.口服抗凝监测。
Br J Gen Pract. 1997 Nov;47(424):747.
本文引用的文献
1
Methods for managing the increased workload in anticoagulant clinics.抗凝门诊应对工作量增加的管理方法。
BMJ. 1996 Feb 3;312(7026):286. doi: 10.1136/bmj.312.7026.286.
2
Near patient testing in primary care.基层医疗中的床边检测
BMJ. 1996 Feb 3;312(7026):263-4. doi: 10.1136/bmj.312.7026.263.
3
Evaluation of a primary care anticoagulant clinic managed by a pharmacist.由药剂师管理的初级保健抗凝诊所的评估。
BMJ. 1996 Mar 2;312(7030):560. doi: 10.1136/bmj.312.7030.560.
4
Prospective comparative study of computer programs used for management of warfarin.用于华法林管理的计算机程序的前瞻性比较研究。
J Clin Pathol. 1993 Apr;46(4):299-303. doi: 10.1136/jcp.46.4.299.
5
Searching for inaccuracy in clinical laboratory testing using Medicare data. Evidence for prothrombin time.
JAMA. 1993 Feb 24;269(8):1030-3.
6
Comparison of anticoagulant control among patients attending general practice and a hospital anticoagulant clinic.普通诊所患者与医院抗凝门诊患者抗凝控制情况的比较。
Br J Gen Pract. 1993 Apr;43(369):152-4.
7
8
Assessment of therapeutic quality control in a long-term anticoagulant trial in post-myocardial infarction patients.
Thromb Haemost. 1994 Sep;72(3):347-51.
9
Use of warfarin in non-rheumatic atrial fibrillation: a commentary from general practice.华法林在非风湿性心房颤动中的应用：来自全科医疗的评论
Br J Gen Pract. 1995 Mar;45(392):153-8.
10
Service provision and use of anticoagulants in atrial fibrillation.心房颤动中抗凝剂的服务提供与使用
BMJ. 1995 Aug 26;311(7004):558-60. doi: 10.1136/bmj.311.7004.558.
Zotero 插件